Proinsulin is a misfolding-prone protein, making its biosynthesis in the endoplasmic reticulum (ER) a stressful event. Pancreatic β-cells overcome ER stress by activating the unfolded protein response (UPR) and reducing insulin production. This suggests that β-cells transition between periods of high insulin biosynthesis and UPR-mediated recovery from cellular stress. We now report the pseudotime ordering of single β-cells from humans without diabetes detected by large-scale RNA sequencing. We identified major states with 1) low UPR and low insulin gene expression, 2) low UPR and high insulin gene expression, or 3) high UPR and low insulin gene expression. The latter state was enriched for proliferating cells. Stressed human β-cells do not dedifferentiate and show little propensity for apoptosis. These data suggest that human β-cells transition between states with high rates of biosynthesis to fulfill the body’s insulin requirements to maintain normal blood glucose levels and UPR-mediated recovery from ER stress due to high insulin production.

β-Cells of the endocrine pancreas produce large amounts of insulin, which is secreted in a finely regulated manner to maintain blood glucose levels within a narrow range. Insulin biosynthesis accounts for >10% of total protein production under basal conditions and increases up to 50% in the stimulated state (1,2). Proinsulin is a misfolding-prone protein because up to 20% of initially synthesized proinsulin fails to reach its mature conformation (36). Misfolded proinsulin is refolded or degraded. Under conditions of high insulin demand, proinsulin misfolding can exceed the capacity of the β-cells to handle the misfolded protein load. This puts pressure on the endoplasmic reticulum (ER) and results in accumulation of misfolded proinsulin and cellular stress. The large demand for proinsulin biosynthesis and folding makes β-cells highly susceptible to ER stress (79).

β-Cells are metabolically active, relying on oxidative phosphorylation for ATP generation (10). This generates reactive oxygen species (ROS) and can result in oxidative stress. β-Cells have low antioxidant defense, further increasing their susceptibility to stress (11,12). ER stress and oxidative stress can enhance each other, because protein misfolding results in the production of ROS, and these species can perturb the ER redox state and cause damage to nascent proteins (13).

To counteract stress conditions, the β-cells activate a network of signaling pathways termed the unfolded protein response (UPR). This is composed of three parallel pathways that are initiated by the ER transmembrane proteins IRE1, PERK, and ATF6 (14). These regulators trigger a signaling cascade that enhances protein folding activity, reduces ER workload, and promotes clearance of misfolded proteins. Once cellular stress is cleared and homeostasis restored, this stress sensor program is deactivated to prevent harmful UPR hyperactivation that could otherwise lead to apoptosis (14).

β-Cell heterogeneity is well established at the functional level. Proteome and transcriptome studies confirmed the heterogeneous nature of mouse and human β-cells and revealed genes and pathways characterizing these subpopulations (15). β-Cell heterogeneity likely represents dynamic states rather than stable and distinct subpopulations because functional studies have shown that β-cells transition between periods of activity and rest. The transitions are not synchronized between β-cells within individual islets (15).

In this study, we applied large-scale RNA sequencing (RNAseq) to single human pancreatic islet cells from donors without diabetes. The β-cells were ordered according to their pseudotime. This was obtained by projecting each cell onto a trajectory, and the ordered sequence of the cells was used to study dynamic changes in gene expression. This provides a higher resolution view of the gene expression landscape due to their dynamic and heterogeneous nature and helps understand the complex biological processes governing β-cell function. We identified distinct states with low UPR and low or high insulin gene expression as well as cells with high UPR activation and low insulin expression. The gene signatures and enriched pathways for each state are described.

Human Islets

Islets from 12 donors without diabetes were obtained from Prodo Laboratories (Supplementary Table 1). Donor information and diabetes status were obtained from the patient’s medical record and, if available, the hemoglobin A1c. Islets were digested at 37°C (10 min) using TrypLE Express (Life Technologies). Cells were filtered (30-µm), centrifuged, and resuspended (1× PBS containing 0.04% BSA). Trypan blue staining revealed 91.2 ± 3.3% (n = 12) cell viability.

RNA Fluorescence In Situ Hybridization

Dissociated cells were placed on slides using Cytospin and fixed (10% neutral buffered formalin) for 35 min. Islets were fixed in the same way, embedded in paraffin, and cut (6-µm sections). Cells and islet sections were permeabilized and hybridized with mRNA probes (INS and DDIT3, FTL, HSPA5, or SQSTM1), according to the manufacturer’s instructions (Advanced Cell Diagnostics). A fluorescent kit was used to amplify the mRNA signal, and fluorescein, Cy3, and Cy5 were detected using a microscope slide scanner (Axio-Scan.Z1; Zeiss). Fluorescence intensities were determined using the HALO image software module for RNA fluorescence in situ hybridization (FISH) analysis (Indica Laboratories).

Single-Cell RNAseq and Read Mapping

Cells were loaded on a Chromium Single Cell Instrument (10x Genomics). RNAseq libraries were prepared using Chromium Single Cell 3′ Library, Gel Beads & Mutiplex Kit (10x Genomics). Sequencing was performed on the Illumina NextSeq500 using Read-1 for transcript read and Read-2 for three indices, I7 index for cell barcode, I5 index for sample index, and unique molecular identifier (UMI). Cell Ranger Single-Cell Software Suite (v1.1.0; 10x Genomics) was used for sample demultiplexing, alignment, filtering, and UMI counting. Human B37.3 Genome assembly and the University of California, Santa Cruz gene model were used for alignment. Single-cell sequencing data described in this study can be found within the Gene Expression Omnibus database using accession number GSE114297.

Single-Cell Data Analysis

Cells were removed if the number of detected genes was <500, total number of UMI was <3,000, or viability score was >0.2 (16). Viability score was defined by the ratio between the sum of MT-RNR2, MT-ND1, MT-CO1, MT-CO2, MT-ATP8, MT-ATP6, MT-CO3, and MT-CYB expression (UMI) and total UMI. A high score indicates low viability. Mclust (R package) was used to assess cell-cell contamination and identify islet endocrine cell types. DensityMclust function estimated bimodal distribution of GCG, INS, SST, PPY, and GHRL expression, namely, high-expression and low-expression modes. Cells with more than one hormone in the high-expression mode were excluded (e.g., GCGhigh and INShigh). Cells with a single-hormone in the high-expression mode were identified as GCG+ (α), INS+ (β), SST+ (δ), PPY+ (PP), and GHRL+ (ε) cells. With the retained single-hormone endocrine and nonendocrine cells, expression data were normalized by the total UMI and scaled by a factor of 10,000 at cell level.

Seurat package identified cell clusters, cell-type subpopulations, and cluster-enriched genes. A total of 1,166 variable genes were used for the principal component analysis. Cell clusters were identified using FindClusters (19 principal components and 0.8 resolution). The first two t-Distributed Stochastic Neighbor Embedding dimensions were used to visualize cell clusters. Enriched genes for each cluster were identified by FindMarkers (>25% cell detection; P < 0.05 and log-scale fold change >0.25). β-Cell subpopulation markers were defined as enriched genes in one subpopulation over the rest of the subpopulations, as described above. Enriched endocrine genes were obtained by comparing endocrine cells (α-, β-, δ-, PP-, and ε-cells) with the nonendocrine cells, as described above.

The alignment analysis of human islet cells between this study and three previous studies (1719) was performed by Seurat using canonical correlation analysis. The union of the top 2,000 variable genes of this study and one published islet study were used to correlate and integrate data from the two studies. Common cell types and subpopulations were aligned between the two studies and visualized in two t-Distributed Stochastic Neighbor Embedding dimensions.

Pseudotime Trajectory Reconstruction

β-Cell subpopulation markers were used by monocle v2.4 (R package) to construct single-cell pseudotime ordering using the default setting. The β-cell trajectory includes two branch points, and branch-dependent significant genes were identified by the BEAM function in monocle. Three sets of genes were derived to capture differential expression between the following branches: INSloUPRhi and INShiUPRlo, INSloUPRlo and INShiUPRlo, and INSloUPRhi and INSloUPRlo. Significant genes were defined (q < 1−10). Cells from two donors were excluded in the pseudotime analysis, because an initial analysis including these cells identified a skewed root state formed almost exclusively by these cells (Supplementary Fig. 1A and B). Cells from 10 other donors exhibited relatively uniform distribution in the trajectory (Supplementary Fig. 1C).

Biological Process Score Calculation

Gene sets of UPR, apoptosis, senescence, and cell cycle were obtained from IPA Ingenuity, SABiosciences (https://www.qiagen.com/us/search/rt2-profiler-pcr-arrays/) and Dominguez et al. (20) (Supplementary Table 2). A score for each process was average of scaled UMI of all genes in the gene set. Score distribution was estimated by random selection of the same number of genes for the specific gene set with 1,000 iterations. The empirical P value was calculated against the distribution of each score.

Pathway Enrichment

Cell markers and branch-dependent genes were analyzed for pathway enrichment with GO, KEGG, and REACTOME by clusterProfiler (R package). Top enriched gene sets were selected based on the P value.

Human β-Cell Subpopulations

Islets isolated from 12 donors without diabetes underwent single-cell RNAseq analysis (Supplementary Table 1). β-Cells were identified based on their INS expression, as detailed in the research design and methods. Clustering of the β-cells according to their transcriptome profiles revealed four subpopulations (Fig. 1A). Three of the subpopulations were similar to each other with only a small number of uniquely enriched genes in each subpopulation: 18 in subpopulation 1, 33 in subpopulation 2, and 18 in subpopulation 3 (Supplementary Table 3). The fourth subpopulation (5.1% of the β-cells; n = 363) was more distinct, with 431 enriched genes. In total, 488 genes were enriched in the subpopulations (Supplementary Table 3). Pathway analysis revealed that genes involved in protein folding and ER stress response are highly enriched in the fourth subpopulation (Fig. 1B). Three other single-cell RNAseq studies (1719) have also identified clusters of human β-cells with an enriched UPR signature (Supplementary Fig. 2). To exclude the possibility that subpopulation 4 represents artificially stressed cells that arose during the single-cell isolation process, we performed RNA FISH on intact islets and dissociated single cells for DDIT3, FTL, HSPA5, and SQSTM1 that were highly enriched in this subpopulation. We identified subsets of INS-positive cells with high expression of these genes at similar frequencies in the intact islet and dissociated single cells (Supplementary Fig. 3). This suggests that induction of the stress response and UPR program is unlikely to originate from the single-cell dissociation process.

Figure 1

Human β-cell subpopulations. A: Human β-cells segregated into four subpopulations (β-sub1, β-sub2, β-sub3, and β-sub4). Other human islet cells are shown in gray. B: Top 5 pathways enriched for β-sub4 subpopulation–enriched genes (P < 1−10). C: Boxplot of INS expression in the β-cell subpopulations. Each gray dot represents an individual β-cell. Each orange dot represents an individual low INS-expressing cell, with a total of 310 cells (β-sub1 = 81, β-sub2 = 116, β-sub3 = 12, and β-sub4 = 101). The difference of INS expression in each β-cell subpopulation was tested by comparing one subpopulation with the other three. INS had significant higher expression in β-sub3 (P = 2.4 × 10−12) and significantly lower expression in β-sub4 (P = 3.1 × 10−58). D: Representative RNA-FISH image of INS (white) and DAPI (blue). Cells with low levels of INS are indicated with a white arrow. E: Histogram of INS log10 fluorescence intensity determined by RNA-FISH analysis. Two thresholds (mean 2*SD and mean 4*SD) were used to define β-cells with normal (β) or low INS expression (β-low). F: Heat map of highly expressed endocrine cell markers showed no differences in expression between the four β-cell subpopulations. Nonendocrine cells are shown for reference.

Figure 1

Human β-cell subpopulations. A: Human β-cells segregated into four subpopulations (β-sub1, β-sub2, β-sub3, and β-sub4). Other human islet cells are shown in gray. B: Top 5 pathways enriched for β-sub4 subpopulation–enriched genes (P < 1−10). C: Boxplot of INS expression in the β-cell subpopulations. Each gray dot represents an individual β-cell. Each orange dot represents an individual low INS-expressing cell, with a total of 310 cells (β-sub1 = 81, β-sub2 = 116, β-sub3 = 12, and β-sub4 = 101). The difference of INS expression in each β-cell subpopulation was tested by comparing one subpopulation with the other three. INS had significant higher expression in β-sub3 (P = 2.4 × 10−12) and significantly lower expression in β-sub4 (P = 3.1 × 10−58). D: Representative RNA-FISH image of INS (white) and DAPI (blue). Cells with low levels of INS are indicated with a white arrow. E: Histogram of INS log10 fluorescence intensity determined by RNA-FISH analysis. Two thresholds (mean 2*SD and mean 4*SD) were used to define β-cells with normal (β) or low INS expression (β-low). F: Heat map of highly expressed endocrine cell markers showed no differences in expression between the four β-cell subpopulations. Nonendocrine cells are shown for reference.

Close modal

In addition to the β-cells described above, we identified 310 cells (4.4%) that clustered with them but express low INS in all four subpopulations (17% on average of β-cells) (Fig. 1C). The existence of low INS-expressing cells (5.6% [n = 34,575]) was confirmed by RNA FISH (Fig. 1D and E). The INS mRNA level was lower in the fourth subpopulation (P = 3.1 × 10−58), because 30% of the cells are low INS-expressing cells. Conversely, INS expression was higher in the third subpopulation (P = 2.4 × 10−12) compared with the rest of the β-cells (Fig. 1C and Supplementary Table 3).

We investigated the differentiation state of the β-cells and found that highly enriched endocrine genes were equally expressed in subpopulation 4 and the other β-cell populations (Fig. 1F). Collectively, these data show that human β-cells segregate into four subpopulations. The cells are fully differentiated, but a subpopulation is characterized by lower INS expression and high levels of UPR-related genes.

Pseudotime Ordering of Human β-Cells

Although cell clustering is useful to identify subtypes, reconstructing cell states in continuous processes is difficult. We therefore used a trajectory analysis to derive pseudotime of the β-cells. To guide construction of the trajectory, we used the 488 subpopulation markers obtained from unbiased clustering. The trajectory constitutes two decision points and five states named by their key features: 1) root (n = 1,079), 2) average INS (n = 317), 3) high INS-low UPR (INShiUPRlo; n = 2,399), 4) low INS-low UPR (INSloUPRlo; n = 1,028), and 5) low INS-high UPR (INSloUPRhi; n = 1,418) (Fig. 2A and B). Expression analysis identified genes whose expressions are different between the branches at decision points 1 and 2 (Supplementary Table 4). Figure 2C–E shows heat maps of the scaled expression of all differentially expressed genes for each branch and pathways with enriched gene sets (Supplementary Tables 5–7). Branch-dependent transcription factor expression and the function of key pathways are described below.

Figure 2

Pseudotime analysis identifies five β-cell states. A: Pseudotime trajectory was reconstructed in the 6,241 β-cells, which contains two branch points. Cells are highlighted by pseudotime ranging from 0 to 8.9. B: States within the pseudotime trajectory are emphasized by different colors. The number of cells per state are indicated. Analysis of branch-dependent genes is presented for INSloUPRhi and INSloUPRlo branches (C), INShiUPRlo and INSloUPRhi branches (D), and INShiUPRlo and INSloUPRlo branches (E). Each heat map presents genes differentially expressed between two branch comparisons, and each row represents the expression level of a gene along the branch trajectory. Enriched pathways are summarized for each gene cluster. GPCR, G-protein–coupled receptor; TCA, tricarboxylic acid.

Figure 2

Pseudotime analysis identifies five β-cell states. A: Pseudotime trajectory was reconstructed in the 6,241 β-cells, which contains two branch points. Cells are highlighted by pseudotime ranging from 0 to 8.9. B: States within the pseudotime trajectory are emphasized by different colors. The number of cells per state are indicated. Analysis of branch-dependent genes is presented for INSloUPRhi and INSloUPRlo branches (C), INShiUPRlo and INSloUPRhi branches (D), and INShiUPRlo and INSloUPRlo branches (E). Each heat map presents genes differentially expressed between two branch comparisons, and each row represents the expression level of a gene along the branch trajectory. Enriched pathways are summarized for each gene cluster. GPCR, G-protein–coupled receptor; TCA, tricarboxylic acid.

Close modal

Transcription Factor Expression in Human β-Cell Pseudotime States

We detected 1,316 transcription factors (1,637 annotated) in human β-cells. Figure 3 shows transcription factors with differential expression in at least one branch, and their associated gene cluster names are shown in Fig. 2C–E. We detected transcription factors associated with ER stress and UPR regulation (ATF3, ATF4, DDIT3, XBP1, and CREB3) (14,21,22), important for β-cell maturation and insulin expression (ISL1, PDX1, MAFA, MAFB, NEUROD1, NKX2-2, and SIX3) (2328), ribosomal biogenesis (GTF3A), and mitochondrial biogenesis (TFB2M) (29,30). We also found that NFE2L2, which is better known as NRF2 and a master regulator of the antioxidant response, is differentially expressed between the INSloUPRlo and INShiUPRlo branches (31). Interestingly, NRF2 protects β-cells from oxidative stress, lipotoxicity, and DNA damage (31,32).

Figure 3

Transcription factors significantly expressed in each pseudotime branch. Transcription factors differentially expressed in each gene cluster are presented for INSloUPRhi and INSloUPRlo branches (A), INShiUPRlo and INSloUPRhi branches (B), and INShiUPRlo and INSloUPRlo branches (C). The gene cluster names are consistent with those shown in Fig. 2C–E.

Figure 3

Transcription factors significantly expressed in each pseudotime branch. Transcription factors differentially expressed in each gene cluster are presented for INSloUPRhi and INSloUPRlo branches (A), INShiUPRlo and INSloUPRhi branches (B), and INShiUPRlo and INSloUPRlo branches (C). The gene cluster names are consistent with those shown in Fig. 2C–E.

Close modal

Insulin Biosynthesis and Stress Recovery Defines Human β-Cell States

INS expression was significantly different between the three pseudotime branches: q = 6.6 × 10−117 between INShiUPRlo and INSloUPRhi, 2.6 × 10−60 between INShiUPRlo and INSloUPRlo, and 1.9 × 10−28 between INSloUPRlo and INSloUPRhi (Supplementary Table 4). The INShiUPRlo state constitutes 38% of all pseudotime-ordered β-cells. Within this state, INS expression was higher than in the other states and increased from 16 to 67% along the branch. At the tip of the branch, we detected extreme expressing cells with up to twofold higher INS expression than the average of the state (Fig. 4A). An important event to consider in single-cell studies is the possible capture of doublet cells. Such an event would be expected to have a higher distribution of gene number and total UMI compared with singlets. Supplementary Fig. 4A and B shows that β-cells in the INShiUPRlo do not have such higher gene number distribution compared with cells in the rest of the states. Therefore, the extreme INS expression is unlikely to reflect the capture of doublets. Among the established activators of insulin biosynthesis, we found MAFA was significantly expressed between the branches (q = 5.1 × 10−14 between INSloUPRlo and INSloUPRhi and 2.3 × 10−13 between INShiUPRlo and INSloUPRhi) (Fig. 3A and B and Fig. 4B). The MAFA expression pattern confirms its importance for regulation of INS expression.

Figure 4

Pseudotime of human β-cells reveals dynamic states of INS expression and stress recovery. Expression pattern in pseudotime ordering of INS (A) and MAFA (B). Composite of factors important for each of the following programs were calculated into a score and its value plotted in pseudotime ordering: UPR (C), apoptosis (D), and senescence (E). Each dot represents a cell colored by the level of composite score.

Figure 4

Pseudotime of human β-cells reveals dynamic states of INS expression and stress recovery. Expression pattern in pseudotime ordering of INS (A) and MAFA (B). Composite of factors important for each of the following programs were calculated into a score and its value plotted in pseudotime ordering: UPR (C), apoptosis (D), and senescence (E). Each dot represents a cell colored by the level of composite score.

Close modal

Genes used to reflect UPR activity were significantly expressed along pseudotime branches, including ATF4, CALR, DDIT3, EIF2A, HSP90B1, HSPA5, HSPH1, NFE2L2, PPP1R15A, VCP, and XBP1 (Supplementary Table 4). To investigate how UPR activation was related to INS expression, we plotted a UPR score along the pseudotime. Surprisingly, the UPR score revealed an inverse expression pattern to INS along the branches with extremes at the tip of the states (Fig. 4C). This was unexpected, given that insulin is the major secretory load in the β-cells that may cause ER stress and UPR activation. However, UPR is a protective mechanism of the cell to cope with stress, and we hypothesize that the INSloUPRhi state reflects recovery from stress coupled with downregulation of insulin expression. A comparable stress-coping mechanism of UPR activation leading to downregulation of insulin gene expression has been shown in mouse β-cells (33).

Consistent with this notion, we failed to observe upregulation of apoptosis markers in the INSloUPRhi state, arguing against the presence of chronic stress with negative consequences for the β-cells. Overall, apoptosis was negligible, with only two β-cells in the INSloUPRhi state and one cell in the UPRloINSlo and root states exhibiting high scores (Fig. 4D). Viability of the cells was also assessed using a score as previously described (16) and further supported the previous findings (Supplementary Fig. 4C). Lastly, we explored the possibility that the pseudotime states reflect the β-cell’s age. No evidence was found to support this because cellular senescence was not increased overall (Fig. 4E). Collectively, the data suggest that β-cells undergo cycles of insulin biosynthesis and stress recovery.

Stress Response in Human β-Cells

β-Cells in the INSloUPRhi state showed activation of the antioxidant defense programs. We detected increased expression of superoxide dismutase isoenzymes, whose function is to catalyze the conversion of superoxide anions into hydrogen peroxide (34). In particular, SOD1 and SOD2 were enriched in the INSloUPRhi state. Antioxidant system genes involved in glutathione metabolism (CD44, GCLM, GSTP1, GLRX2, GLRX3, GPX1, GPX2, GPX3, GPX4, and SLC3A2), thioredoxin metabolism (PRDX1, PRDX2, PRDX6, TXN, TXNL1, and TXNRD1), quinone detoxification (NQO1), and iron storage (FTH1, FTL, and PCBP1) were also enriched in the INSloUPRhi state and protect against ROS (Fig. 5) (3437).

Figure 5

During stress recovery, human β-cells activate an antioxidant program. A: Schematic summarizing the different pathways contributing to cell protection from ROS. The first is iron sequestration by ferritin light and heavy chain (FTL, FTH) and poly(rC)-binding protein 1 (PCBP1). The second is superoxide dismutases (SOD1, SOD2, SOD3). The third is glutathione production, utilization, and regeneration, which includes the glutamate–cysteine ligase complex modifier subunit (GCLM), glutathione S-transferase (GSTP1), glutaredoxins (GLRX2, GLRX3), glutathione peroxidases (GPX1, GPX2, GPX3, GPX4), and the system Xct structural component and stabilizer unit (SLC3A2, CD44). The fourth is composed of thioredoxin production, utilization, and regeneration, which is regulated by thioredoxin (TXN), thioredoxin reductase 1 (TXNRD1), thioredoxin like-1 (TXNL1), and peroxiredoxins (PRDX1, PRDX2, PRDX6). The fifth is quinone detoxification by NAD(P)H quinone dehydrogenase 1 (NQO1). B: Expression heat map showing significantly expressed genes between INShiUPRlo and INSloUPRhi branches, which are presented in A.

Figure 5

During stress recovery, human β-cells activate an antioxidant program. A: Schematic summarizing the different pathways contributing to cell protection from ROS. The first is iron sequestration by ferritin light and heavy chain (FTL, FTH) and poly(rC)-binding protein 1 (PCBP1). The second is superoxide dismutases (SOD1, SOD2, SOD3). The third is glutathione production, utilization, and regeneration, which includes the glutamate–cysteine ligase complex modifier subunit (GCLM), glutathione S-transferase (GSTP1), glutaredoxins (GLRX2, GLRX3), glutathione peroxidases (GPX1, GPX2, GPX3, GPX4), and the system Xct structural component and stabilizer unit (SLC3A2, CD44). The fourth is composed of thioredoxin production, utilization, and regeneration, which is regulated by thioredoxin (TXN), thioredoxin reductase 1 (TXNRD1), thioredoxin like-1 (TXNL1), and peroxiredoxins (PRDX1, PRDX2, PRDX6). The fifth is quinone detoxification by NAD(P)H quinone dehydrogenase 1 (NQO1). B: Expression heat map showing significantly expressed genes between INShiUPRlo and INSloUPRhi branches, which are presented in A.

Close modal

As mentioned above, NRF2 (NFE2L2) is a master regulator of the antioxidant response and controls the expression of the superoxide dismutase isoenzymes and genes involved in glutathione and thioredoxin production and utilization as well as iron detoxification and storage (31). Factors promoting the activation or stabilization of NRF2 (SQSTM1, PARK7, CDKN1A, and MANF) were enriched in the INSloUPRhi state (3841). In addition, expression of genes encoding the inhibitor of differentiation proteins (ID1-3) showed progressive upregulation in the INSloUPRhi state (Fig. 5B). ID1-3 are important antioxidant response factors crucial for β-cell survival under stress and are associated with positive regulation of the NRF2-interacting proteins, called small MAF proteins (42). Thus, β-cells cope with stress by reducing insulin expression and activating NRF2-dependent antioxidant defense mechanisms.

INSloUPRhi State Promotes Human β-Cell Proliferation

Mouse β-cells proliferate under conditions of UPR activation and low insulin production (43,44). Because these conditions are hallmarks of β-cells in the INSloUPRhi state, we investigated the existence and location of proliferating β-cells using a proliferation score consisting of 67 cell-cycle genes (Supplementary Table 2). Interestingly, most proliferating human β-cells were found at the tip of the INSloUPRhi state, with only few cells in the INShiUPRlo and root states. More proliferating cells were in the G1S than in the G2M cell cycle phase (Fig. 6A and B). Among UPR activation and INS expression, we found low INS expression was associated with proliferation (Fig. 6C).

Figure 6

Human β-cells proliferate more in a state of low INS expression. Scores of composites of cell cycle regulatory genes were calculated and used to identify cells in G1S phase (A) and G2M phase (B). Each dot represents a cell colored by the score of the appropriate gene set. Percentage of cells for each cell cycle phase relative to total cells for the state is shown. C: β-Cells from all pseudotime states were plotted against their UPR score and INS expression (UMI). Proliferating β-cells, which are highlighted in red, were identified by empirical P < 0.001 for the G1S or G2M cell cycle scores.

Figure 6

Human β-cells proliferate more in a state of low INS expression. Scores of composites of cell cycle regulatory genes were calculated and used to identify cells in G1S phase (A) and G2M phase (B). Each dot represents a cell colored by the score of the appropriate gene set. Percentage of cells for each cell cycle phase relative to total cells for the state is shown. C: β-Cells from all pseudotime states were plotted against their UPR score and INS expression (UMI). Proliferating β-cells, which are highlighted in red, were identified by empirical P < 0.001 for the G1S or G2M cell cycle scores.

Close modal

NR0B1 and ZNF143 were among the enriched transcription factors in this state and play important roles for embryonic stem cell self-renewal and proliferation (Fig. 3A and B). ZNF143 is a positive regulator of multiple cell-cycle genes and is a component of a transcriptional network that regulates cell proliferation (45,46). Furthermore, HES1 expression was increased in the stressed β-cells and regulates proliferation in progenitor cells through inhibition of CDKN1B (Fig. 3B) (47). HES4 was also enriched in this state and is associated with maintenance of stem cell features (48). Lastly, LYAR expression was higher in the INSloUPRhi state and is involved in the regulation of mouse β-cell proliferation (Fig. 3B) (49). Together, these results extend the observations in mice that low insulin expression but not UPR activation signals for human β-cells to proliferate.

Human β-Cell Stress Recovery Is Metabolically Demanding

A surprising observation is that β-cells in the INSloUPRhi state had high expression of genes involved in energy production. In particular, we found upregulation of genes in the glycolytic pathway, tricarboxylic acid cycle, and the electron transport chain (Fig. 7). In addition, β-cells in the INSloUPRhi state showed upregulation of genes (G6PD, RPIA, TALDO, and TKT) encoding enzymes in the pentose phosphate pathway (Fig. 7A). This pathway provides ribose-5-phosphate and NADPH for nucleic acid synthesis. NADPH is used as a reducing agent in the synthetic steps of fatty acids and steroid hormones along with several detoxification systems; for example, NADPH is the limiting substrate for glutathione reductase (50). More importantly, G6PD is the rate-limiting enzyme in the pentose phosphate pathway and increases nucleotide production favoring cell survival and proliferation (51,52). Mice deficient in G6PD are glucose intolerant and have smaller islets (51). These data suggest that G6PD might play a role in human β-cell growth and survival. Collectively, the data suggest that β-cells in the INSloUPRhi state use more energy than cells undertaking higher levels of INS expression. The shift toward a more active pentose phosphate pathway is likely advantageous for stress recovery and in providing building blocks for cell proliferation.

Figure 7

Stress recovery increases metabolic demand in human β-cells. A: Heat map of significantly expressed genes between the INShiUPRlo and INSloUPRhi branches. The genes are involved in glycolysis, lactate production, pentose phosphate pathway, or tricarboxylic acid (TCA) cycle. B: Complexes of electron transport chain (ETC) are presented as individual clusters. C: Working model summarizing the findings presented in A and B.

Figure 7

Stress recovery increases metabolic demand in human β-cells. A: Heat map of significantly expressed genes between the INShiUPRlo and INSloUPRhi branches. The genes are involved in glycolysis, lactate production, pentose phosphate pathway, or tricarboxylic acid (TCA) cycle. B: Complexes of electron transport chain (ETC) are presented as individual clusters. C: Working model summarizing the findings presented in A and B.

Close modal

In this study, we detected heterogeneity among human β-cells. Pseudotime analysis ordered the β-cells into five states with varying degrees of insulin gene expression and UPR activation. Unexpectedly, we found that UPR was activated in a subset of β-cells expressing low levels of INS (INSloUPRhi) and appear to represent a state of recovery from stress. The high levels of INS expression observed in the INShiUPRlo state are likely to represent a state of active production. Although we did not observe many changes in the expression of factors known to participate in its biosynthesis, it is possible that these are regulated at the posttranslational level or are not rate limiting in this setting. We found little evidence for apoptosis and dedifferentiation among the β-cells in the different states. Markers of β-cell dedifferentiation, including NEUROG3, OCT4, and NANOG, were barely detected or absent under these nondiabetic conditions (53). Interestingly, most of the β-cells with a high proliferation score were found in the INSloUPRhi state. This is similar to the situation in mouse β-cells (43,44). We also found that β-cells in the INSloUPRhi state have higher expression of genes involved in energy metabolism than cells in the other states. Based on these data, we postulate that human β-cells transition between states of high insulin production, which is likely to cause cellular stress due to the high propensity of proinsulin to misfold, and states of low insulin biosynthesis and increased UPR-mediated stress recovery (Fig. 8). Oscillation between periods of activity and recovery is supported by studies demonstrating functional heterogeneity among β-cells (15).

Figure 8

Human β-cells traverse through dynamic states to meet insulin demands. Model showing that β-cells undergoing extremely high insulin biosynthesis (INSex-hi) are likely to become stressed and retire for a period of recovery (INSex-loUPRhi) that entails UPR activation and low INS expression. This process is followed by a transitioning state where INS is still low and UPR activity is decreased (INSloUPRlo); β-cells are then ready to resume high insulin expression (INShiUPRlo). Under these states, proliferation was preferentially found under a state of low INS expression and high UPR activation.

Figure 8

Human β-cells traverse through dynamic states to meet insulin demands. Model showing that β-cells undergoing extremely high insulin biosynthesis (INSex-hi) are likely to become stressed and retire for a period of recovery (INSex-loUPRhi) that entails UPR activation and low INS expression. This process is followed by a transitioning state where INS is still low and UPR activity is decreased (INSloUPRlo); β-cells are then ready to resume high insulin expression (INShiUPRlo). Under these states, proliferation was preferentially found under a state of low INS expression and high UPR activation.

Close modal

Humans are endowed with a large number of pancreatic islets. Each islet contains ∼50% β-cells, and each cell expresses thousands of insulin-containing granules (54,55). Only a small fraction of the insulin secretory granules is typically released to maintain normal blood glucose levels (55). This suggests spare β-cell capacity and is supported by partial pancreatectomy studies demonstrating that humans only start to develop impaired glucose tolerance after removal of approximately half of their pancreas and, consequently, half of the β-cell mass (56,57). Assuming that the remaining β-cells oscillate between periods of high insulin biosynthesis (activity) and UPR-mediated stress recovery (rest), the partial pancreatectomy studies suggest that less than half of the β-cells are active at any given time. Furthermore, β-cells in the active state have different glucose thresholds for stimulation of insulin secretion (15). Collectively, these data show that β-cells undergo periods of activity and rest, which requires spare capacity. A snapshot of the dynamic processes that β-cells undergo could be interpreted as static conditions rather than transition states. This is an important consideration when single-cell RNAseq data are analyzed. Therefore, applying pseudotime analysis allowed us to follow the progression of gene expression changes leading to each of the five interconnected β-cell states. We postulate that β-cells transition between states of activity with high insulin expression and recovery. We provide unprecedented insights into the human β-cell transcriptome and the gene changes associated with these functional states.

MAFA is a transcription factor regulating insulin gene transcription (25) and was one of few genes with increased expression in the INShiUPRlo state. Assuming active insulin secretion in this state, the lack of expression changes in genes encoding the β-cell stimulus-secretion coupling and secretory machinery indicate that they are not rate limiting at the transcriptional level for the secretion of the newly formed insulin. On the contrary, we observed many genes with increased expression in the INSloUPRhi state. In particular, we found genes involved in reducing cellular stress as well as in providing energy and substrates for the stress recovery processes. We also detected increased rates of β-cell proliferation in the INSloUPRhi state. Interestingly, our data do not support a correlation between proliferation and UPR activity but rather with low insulin gene expression. We did not detect dedifferentiated human β-cells, even among the lowest insulin expressing cells. This excludes the possibility that dedifferentiation is a trigger of β-cell proliferation.

Pseudotime analysis of single human β-cell RNAseq data from patients with type 2 diabetes could provide valuable information on shifts in the time that β-cells spend in the different states and the associated changes in gene expression. It is tempting to speculate that during chronic high blood glucose and insulin demand, β-cells spend a larger proportion of their time in the high insulin gene expression state and less time in the recovery state. This could lead to chronic stress and eventually cell death. Indeed, patients with type 2 diabetes have 20–65% reduced β-cell mass (58). It would also be interesting to investigate the effects of diabetes medications on the distribution of human β-cells between the states to predict the potential for maintenance of good glycemic control for extended periods of time or risk for β-cell exhaustion and failure.

The identification of functional states is not unique to the β-cells among the pancreatic islet cells. In this sequencing effort, we found human α-cells segregated into two closely related clusters with similar GCG expression and UPR scores and a subpopulation with strong expression of cell cycle genes and low UPR score. The reason why human β-cells but not human α-cells become stressed and need to transition between states of activity and rest is an important subject for future investigations.

Y.X. and G.D.G. are co–first authors.

Acknowledgments. The authors thank Samantha Intriligator (Regeneron Pharmaceuticals) for her help with preparing the manuscript.

Funding. The studies were funded by Regeneron Pharmaceuticals.

Duality of Interest. All authors are employees and shareholders of Regeneron Pharmaceuticals. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. Y.X., G.D.G., H.O., J.K., A.-H.L., and J.G. analyzed the data. Y.X., G.D.G., H.O., J.K., and J.G. designed the studies. Y.X., G.D.G., A.-H.L., G.D.Y., A.J.M., and J.G. wrote the manuscript. G.D.G., J.K., C.A., and M.N. conducted the studies. Y.X. and J.G. are the guarantors of this work and, as such, had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Scheuner
D
,
Kaufman
RJ
.
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes
.
Endocr Rev
2008
;
29
:
317
333
[PubMed]
2.
Schuit
FC
,
In’t Veld
PA
,
Pipeleers
DG
.
Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells
.
Proc Natl Acad Sci U S A
1988
;
85
:
3865
3869
[PubMed]
3.
Liu
M
,
Haataja
L
,
Wright
J
, et al
.
Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport
.
PLoS One
2010
;
5
:
e13333
[PubMed]
4.
Liu
M
,
Li
Y
,
Cavener
D
,
Arvan
P
.
Proinsulin disulfide maturation and misfolding in the endoplasmic reticulum
.
J Biol Chem
2005
;
280
:
13209
13212
[PubMed]
5.
Wang
J
,
Chen
Y
,
Yuan
Q
,
Tang
W
,
Zhang
X
,
Osei
K
.
Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic β-cells
.
PLoS One
2011
;
6
:
e19446
[PubMed]
6.
Wang
J
,
Osei
K
.
Proinsulin maturation disorder is a contributor to the defect of subsequent conversion to insulin in β-cells
.
Biochem Biophys Res Commun
2011
;
411
:
150
155
[PubMed]
7.
Eizirik
DL
,
Cardozo
AK
,
Cnop
M
.
The role for endoplasmic reticulum stress in diabetes mellitus
.
Endocr Rev
2008
;
29
:
42
61
[PubMed]
8.
Papa
FR
.
Endoplasmic reticulum stress, pancreatic β-cell degeneration, and diabetes
.
Cold Spring Harb Perspect Med
2012
;
2
:
a007666
[PubMed]
9.
Vetere
A
,
Choudhary
A
,
Burns
SM
,
Wagner
BK
.
Targeting the pancreatic β-cell to treat diabetes
.
Nat Rev Drug Discov
2014
;
13
:
278
289
[PubMed]
10.
Schuit
F
,
De Vos
A
,
Farfari
S
, et al
.
Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells
.
J Biol Chem
1997
;
272
:
18572
18579
[PubMed]
11.
Lenzen
S
,
Drinkgern
J
,
Tiedge
M
.
Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues
.
Free Radic Biol Med
1996
;
20
:
463
466
[PubMed]
12.
Tiedge
M
,
Lortz
S
,
Drinkgern
J
,
Lenzen
S
.
Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells
.
Diabetes
1997
;
46
:
1733
1742
[PubMed]
13.
Hasnain
SZ
,
Prins
JB
,
McGuckin
MA
.
Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
.
J Mol Endocrinol
2016
;
56
:
R33
R54
[PubMed]
14.
Fonseca
SG
,
Gromada
J
,
Urano
F
.
Endoplasmic reticulum stress and pancreatic β-cell death
.
Trends Endocrinol Metab
2011
;
22
:
266
274
[PubMed]
15.
Gutierrez
GD
,
Gromada
J
,
Sussel
L
.
Heterogeneity of the pancreatic beta cell
.
Front Genet
2017
;
8
:
22
[PubMed]
16.
Xin
Y
,
Kim
J
,
Okamoto
H
, et al
.
RNA sequencing of single human islet cells reveals type 2 diabetes genes
.
Cell Metab
2016
;
24
:
608
615
[PubMed]
17.
Baron
M
,
Veres
A
,
Wolock
SL
, et al
.
A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure
.
Cell Syst
2016
;
3
:
346
360.e4
18.
Segerstolpe
Å
,
Palasantza
A
,
Eliasson
P
, et al
.
Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes
.
Cell Metab
2016
;
24
:
593
607
[PubMed]
19.
Muraro
MJ
,
Dharmadhikari
G
,
Grun
D
, et al
.
A single-cell transcriptome atlas of the human pancreas
. Cell Syst
2016
;
3
:
385
394.e3
20.
Dominguez
D
,
Tsai
YH
,
Gomez
N
,
Jha
DK
,
Davis
I
,
Wang
Z
.
A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer
.
Cell Res
2016
;
26
:
946
962
[PubMed]
21.
Liang
G
,
Audas
TE
,
Li
Y
, et al
.
Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress response protein Herp through an ER stress response element
.
Mol Cell Biol
2006
;
26
:
7999
8010
[PubMed]
22.
Jiang
HY
,
Wek
SA
,
McGrath
BC
, et al
.
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response
.
Mol Cell Biol
2004
;
24
:
1365
1377
[PubMed]
23.
Ediger
BN
,
Du
A
,
Liu
J
, et al
.
Islet-1 is essential for pancreatic β-cell function
.
Diabetes
2014
;
63
:
4206
4217
[PubMed]
24.
Gao
T
,
McKenna
B
,
Li
C
, et al
.
Pdx1 maintains β cell identity and function by repressing an α cell program
.
Cell Metab
2014
;
19
:
259
271
[PubMed]
25.
Hang
Y
,
Stein
R
.
MafA and MafB activity in pancreatic β cells
.
Trends Endocrinol Metab
2011
;
22
:
364
373
[PubMed]
26.
Gu
C
,
Stein
GH
,
Pan
N
, et al
.
Pancreatic beta cells require NeuroD to achieve and maintain functional maturity
.
Cell Metab
2010
;
11
:
298
310
[PubMed]
27.
Gutiérrez
GD
,
Bender
AS
,
Cirulli
V
, et al
.
Pancreatic β cell identity requires continual repression of non-β cell programs
.
J Clin Invest
2017
;
127
:
244
259
[PubMed]
28.
Arda
HE
,
Li
L
,
Tsai
J
, et al
.
Age-dependent pancreatic gene regulation reveals mechanisms governing human β cell function
.
Cell Metab
2016
;
23
:
909
920
[PubMed]
29.
Sloan
KE
,
Bohnsack
MT
,
Watkins
NJ
.
The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress
.
Cell Rep
2013
;
5
:
237
247
[PubMed]
30.
Nicholas
LM
,
Valtat
B
,
Medina
A
, et al
.
Mitochondrial transcription factor B2 is essential for mitochondrial and cellular function in pancreatic β-cells
.
Mol Metab
2017
;
6
:
651
663
[PubMed]
31.
Ma
Q
.
Role of nrf2 in oxidative stress and toxicity
.
Annu Rev Pharmacol Toxicol
2013
;
53
:
401
426
[PubMed]
32.
Abebe
T
,
Mahadevan
J
,
Bogachus
L
, et al
.
Nrf2/antioxidant pathway mediates β cell self-repair after damage by high-fat diet-induced oxidative stress
.
JCI Insight
2017
;
2
[PubMed]
33.
Lipson
KL
,
Fonseca
SG
,
Ishigaki
S
, et al
.
Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1
.
Cell Metab
2006
;
4
:
245
254
[PubMed]
34.
Espinosa-Diez
C
,
Miguel
V
,
Mennerich
D
, et al
.
Antioxidant responses and cellular adjustments to oxidative stress
.
Redox Biol
2015
;
6
:
183
197
[PubMed]
35.
Gray
JP
,
Karandrea
S
,
Burgos
DZ
,
Jaiswal
AA
,
Heart
EA
.
NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells
.
Toxicol Lett
2016
;
262
:
1
11
[PubMed]
36.
Orino
K
,
Lehman
L
,
Tsuji
Y
,
Ayaki
H
,
Torti
SV
,
Torti
FM
.
Ferritin and the response to oxidative stress
.
Biochem J
2001
;
357
:
241
247
[PubMed]
37.
Shi
H
,
Bencze
KZ
,
Stemmler
TL
,
Philpott
CC
.
A cytosolic iron chaperone that delivers iron to ferritin
.
Science
2008
;
320
:
1207
1210
[PubMed]
38.
Clements
CM
,
McNally
RS
,
Conti
BJ
,
Mak
TW
,
Ting
JP
.
DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
.
Proc Natl Acad Sci U S A
2006
;
103
:
15091
15096
[PubMed]
39.
Jain
A
,
Lamark
T
,
Sjøttem
E
, et al
.
p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription
.
J Biol Chem
2010
;
285
:
22576
22591
[PubMed]
40.
Chen
W
,
Sun
Z
,
Wang
XJ
, et al
.
Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response
.
Mol Cell
2009
;
34
:
663
673
[PubMed]
41.
Zhang
J
,
Tong
W
,
Sun
H
, et al
.
Nrf2-mediated neuroprotection by MANF against 6-OHDA-induced cell damage via PI3K/AKT/GSK3β pathway
.
Exp Gerontol
2017
;
100
:
77
86
[PubMed]
42.
Bensellam
M
,
Montgomery
MK
,
Luzuriaga
J
,
Chan
JY
,
Laybutt
DR
.
Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells
.
Diabetologia
2015
;
58
:
758
770
[PubMed]
43.
Sharma
RB
,
O’Donnell
AC
,
Stamateris
RE
, et al
.
Insulin demand regulates β cell number via the unfolded protein response
.
J Clin Invest
2015
;
125
:
3831
3846
[PubMed]
44.
Szabat
M
,
Page
MM
,
Panzhinskiy
E
, et al
.
Reduced insulin production relieves endoplasmic reticulum stress and induces β cell proliferation
.
Cell Metab
2016
;
23
:
179
193
[PubMed]
45.
Khalfallah
O
,
Rouleau
M
,
Barbry
P
,
Bardoni
B
,
Lalli
E
.
Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation
.
Stem Cells
2009
;
27
:
1529
1537
[PubMed]
46.
Parker
JB
,
Yin
H
,
Vinckevicius
A
,
Chakravarti
D
.
Host cell factor-1 recruitment to E2F-bound and cell-cycle-control genes is mediated by THAP11 and ZNF143
.
Cell Rep
2014
;
9
:
967
982
[PubMed]
47.
Murata
K
,
Hattori
M
,
Hirai
N
, et al
.
Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1
.
Mol Cell Biol
2005
;
25
:
4262
4271
[PubMed]
48.
El Yakoubi
W
,
Borday
C
,
Hamdache
J
, et al
.
Hes4 controls proliferative properties of neural stem cells during retinal ontogenesis
.
Stem Cells
2012
;
30
:
2784
2795
[PubMed]
49.
Klochendler
A
,
Caspi
I
,
Corem
N
, et al
.
The genetic program of pancreatic β-cell replication in vivo
.
Diabetes
2016
;
65
:
2081
2093
[PubMed]
50.
Riganti
C
,
Gazzano
E
,
Polimeni
M
,
Aldieri
E
,
Ghigo
D
.
The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate
.
Free Radic Biol Med
2012
;
53
:
421
436
[PubMed]
51.
Zhang
Z
,
Liew
CW
,
Handy
DE
, et al
.
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis
.
FASEB J
2010
;
24
:
1497
1505
[PubMed]
52.
Stanton
RC
.
Glucose-6-phosphate dehydrogenase, NADPH, and cell survival
.
IUBMB Life
2012
;
64
:
362
369
[PubMed]
53.
Talchai
C
,
Xuan
S
,
Lin
HV
,
Sussel
L
,
Accili
D
.
Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure
.
Cell
2012
;
150
:
1223
1234
[PubMed]
54.
Ichii
H
,
Inverardi
L
,
Pileggi
A
, et al
.
A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations
.
Am J Transplant
2005
;
5
:
1635
1645
[PubMed]
55.
Rorsman
P
,
Renström
E
.
Insulin granule dynamics in pancreatic beta cells
.
Diabetologia
2003
;
46
:
1029
1045
[PubMed]
56.
Kendall
DM
,
Sutherland
DE
,
Najarian
JS
,
Goetz
FC
,
Robertson
RP
.
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans
.
N Engl J Med
1990
;
322
:
898
903
[PubMed]
57.
Menge
BA
,
Schrader
H
,
Breuer
TG
, et al
.
Metabolic consequences of a 50% partial pancreatectomy in humans
.
Diabetologia
2009
;
52
:
306
317
[PubMed]
58.
Meier
JJ
,
Bonadonna
RC
.
Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes
.
Diabetes Care
2013
;
36
(
Suppl. 2
):
S113
S119
[PubMed]
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Supplementary data